Timing could make a difference: new results suggest that patients with glioblastoma who took temozolomide (Temodar) in the morning rather
Morning (vs Evening) Dosing and Better Survival in Glioblastoma
Home ยป
Researchers reveal novel therapeutic target in the treatment of certain cancers
Mount Sinai Researchers Find "Removal of AKAP11 Protein by Autophagy as a key to Fuel Mitochondrial Metabolism and Tumor Cell
Researchers reveal novel therapeutic target in the treatment of certain cancers
Mount Sinai Researchers Find "Removal of AKAP11 Protein by Autophagy as a key to Fuel Mitochondrial Metabolism and Tumor Cell
Case study of rare nervous system tumor reveals hypermutation
While deadly, gliosarcomas are a rare central nervous system tumor often overshadowed in research by more common tumors. These sarcomas
VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor
Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of
Study finds high tumor mutation burden predicts immunotherapy response in some, but not all, cancers
A high rate of genetic mutations within a tumor, known as high tumor mutation burden (TMB), was only useful for
Lack of Skin Biopsy Equipment Could Mean Delayed Diagnosis
NEW YORK (Reuters Health) – Low-income countries that lack the necessary equipment for skin biopsies may not be able to
Study explores impact of surgical delay for renal cell carcinoma during COVID-19 pandemic
During the peak of the COVID-19 pandemic, several elective surgeries for renal cell carcinoma, the most common type of kidney
Exposure to nighttime artificial lights linked with higher risk of thyroid cancer
People living in regions with high levels of outdoor artificial light at night may face a higher risk of developing
Hallmarks of Cancer
There are six features, or hallmarks, of cancer that are used to organize our understanding of the stage of the